Search Results
Understanding Cardiovascular Outcomes Trials
Examining Cardiovascular Outcomes Trials
Professor Stephen Wiviott - 'SGLT2 Outcome trials - an evolving story'
Cardiovascular Outcomes Trials With Anti-Diabetes Medications
Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors
DRF 19: Cardiovascular Outcomes for Diabetes Drugs: Lessons Learned and Path Forward
CV Effects of Diabetes Medications: Lessons learned from Cardiovascular Outcomes Trials
Evidence Based Reduction of Cardiovascular & Renal Outcomes in Diabetes
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond
ADA 2020: Findings from EMPA-REG OUTCOME trial — Dr Muthiah Vaduganathan
Semaglutide and Cardiovascular Outcomes in Obesity | NEJM
UCC presents Professor Neil R Poulter CV Outcome Trials in Type 2 Diabetes: A Review